Magnetic resonance imaging–ultrasound fusion-targeted biopsy combined with systematic 12-core ultrasound-guided biopsy improves the detection of clinically significant prostate cancer: Are we ready to abandon the systematic approach?

BACKGROUND: Multiparametric (mp) magnetic resonance imaging (MRI)–ultrasound fusion-targeted biopsy (TB) has improved the detection of clinically significant prostate cancer (csCaP) using the Prostate Imaging Reporting and Data System (PI-RADS) reporting system, leading some authors to conclude that...

Descripción completa

Detalles Bibliográficos
Autores principales: Febres-Aldana, Christopher Antonio, Alghamdi, Sarah, Weppelmann, Thomas A., Lastarria, Emilio, Bhandari, Akshay, Omarzai, Yumna, Poppiti, Robert J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992529/
https://www.ncbi.nlm.nih.gov/pubmed/33776334
http://dx.doi.org/10.4103/UA.UA_123_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992529/
https://www.ncbi.nlm.nih.gov/pubmed/33776334
http://dx.doi.org/10.4103/UA.UA_123_19

Ejemplares similares